Lipid-lowering drugs and the risk of depression and suicidal behavior.
about
Depressogenic effects of medications: a reviewNeuropsychiatric consequences of cardiovascular medicationsPleiotropic effects of statinsThe "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Statin Therapy: Review of Safety and Potential Side EffectsNon-psychotropic medication and risk of suicide or attempted suicide: a systematic reviewNeuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depressionUnintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa?The impact of statins on psychological wellbeing: a systematic review and meta-analysis.Statins, mood, sleep, and physical function: a systematic reviewMolecular mechanisms underlying the effects of statins in the central nervous system.Statin use and risk of depression: a Swedish national cohort study.Prospects of statins in Parkinson diseaseLipid-lowering drugs.Benefit/risk ratio of statins in primary prevention.Improvement of Glycemic Control in Insulin-Dependent Diabetics with Depression by Concomitant Treatment with AntidepressantsLovastatin potentiates the antidepressant efficacy of fluoxetine in rats.The effects of statins on mood: a review of the literature.The controversy of a wider statin utilization: why?Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.Risk of Incident Antidepressant-Treated Depression Associated with Use of 5α-Reductase Inhibitors Compared with Use of α-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink.Do Statins Have Antidepressant Effects?Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts).Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects.Risk of incident depression in patients with Parkinson disease in the UK.BMI and risk factors for suicide: why is BMI inversely related to suicide?The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.
P2860
Q24635465-978359AB-AF35-4861-89E6-0DD9AF12732DQ24635624-5BE0F88D-9E23-4621-B5A7-B4670B0A6CE5Q24647863-7DF253D3-046D-4545-986C-527B30E16E67Q24796000-824B3B64-6240-42C8-896B-83AB92698168Q28072883-98D8FC0F-27A8-4125-AFE0-7F38B1537299Q28078315-79E400E0-575B-42C3-BDF6-323040C9056DQ28220405-756B27C6-6D2E-4BB3-B6FA-867E1B93E891Q34411415-A59CEC8E-4CD9-49E8-B5E1-557D066B9BE8Q34432313-27270570-5D66-4904-9A63-859CD91CEA0FQ34498512-3AA342BD-0C92-4660-8251-B5E90131A62BQ34498604-DAC7BB9F-C0C2-4320-9E36-AE6C031CD9F9Q34685463-30D48A1D-E04B-494F-9289-92E06B702B6BQ34706559-F4403B28-664C-4CBF-9DDD-7F2F1EF65EEAQ35094028-4C4FD056-79A1-4396-8DD9-457E86B45CEBQ36002780-0FE8F4EB-5DE2-4C89-AC94-6C1641FF54D4Q36835515-BFCC611A-C151-47BE-A62F-2ECA01CEB568Q37036035-CC9D1E41-E598-4914-8798-92DCC16798B2Q37153469-EC00D8AD-8C6E-4861-8FEF-522B945D2897Q37793599-D991C0C4-959D-4D06-8BE1-1B50EC4B6033Q38089090-9CA3542A-8BDB-4D41-8CB0-25FC4F9AC9CBQ38151984-124BBF6A-DC3D-47CF-A2AF-EAA394114304Q38179262-35616668-69D1-4ACB-ABE9-4710101C7393Q38742876-497C80B0-AA99-4C60-B641-0241801AD845Q38753419-7A8A2AC4-BF36-4CC0-AF24-DF2A9E97D56BQ38906881-46B017F1-5CB7-4F74-9ACC-569BB9EC7D6FQ39183235-2067B013-894B-4B10-99CD-8A123ED007BFQ40455521-3D1781BB-FCA1-4321-B144-6E700D89652EQ40749749-9737B1EC-C719-4E08-9859-EEA5EF10CCEFQ44696944-1ED7CEA2-D417-40FE-8B17-2F37DD290450Q46121279-5083F62B-BC28-42E5-B24D-AABCFCF37E10Q46392397-50FAAD5C-BD48-4C6B-8535-521AC60F7C4E
P2860
Lipid-lowering drugs and the risk of depression and suicidal behavior.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Lipid-lowering drugs and the risk of depression and suicidal behavior.
@en
type
label
Lipid-lowering drugs and the risk of depression and suicidal behavior.
@en
prefLabel
Lipid-lowering drugs and the risk of depression and suicidal behavior.
@en
P921
P1476
Lipid-lowering drugs and the risk of depression and suicidal behavior.
@en
P2093
Chen-Chang Yang
P304
P356
10.1001/ARCHINTE.163.16.1926
P407
P577
2003-09-01T00:00:00Z